Daniel K.C. Lee

1.2k total citations
39 papers, 876 citations indexed

About

Daniel K.C. Lee is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Daniel K.C. Lee has authored 39 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Physiology, 30 papers in Pulmonary and Respiratory Medicine and 16 papers in Immunology and Allergy. Recurrent topics in Daniel K.C. Lee's work include Asthma and respiratory diseases (33 papers), Respiratory and Cough-Related Research (23 papers) and Allergic Rhinitis and Sensitization (15 papers). Daniel K.C. Lee is often cited by papers focused on Asthma and respiratory diseases (33 papers), Respiratory and Cough-Related Research (23 papers) and Allergic Rhinitis and Sensitization (15 papers). Daniel K.C. Lee collaborates with scholars based in United Kingdom, Canada and United States. Daniel K.C. Lee's co-authors include Brian J. Lipworth, Graeme P. Currie, Kay Haggart, Catherine Jackson, Tom Fardon, Lesley C. McFarlane, John J. Lima, Ian P. Hall, Thomas C. Fardon and Robert D. Gray and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Daniel K.C. Lee

36 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel K.C. Lee United Kingdom 18 742 613 239 76 36 39 876
W. Stricker United States 11 821 1.1× 652 1.1× 434 1.8× 50 0.7× 67 1.9× 14 1.0k
Kay Haggart United Kingdom 14 536 0.7× 432 0.7× 247 1.0× 39 0.5× 49 1.4× 19 648
Dorothy J. Margolskee United States 10 641 0.9× 460 0.8× 183 0.8× 77 1.0× 9 0.3× 15 768
Robert Murdoch United Kingdom 17 393 0.5× 339 0.6× 95 0.4× 111 1.5× 34 0.9× 33 641
Sümeyye Alparslan Bekir Türkiye 5 248 0.3× 223 0.4× 54 0.2× 58 0.8× 3 0.1× 14 352
Larry Gontovnick Canada 8 265 0.4× 216 0.4× 38 0.2× 42 0.6× 4 0.1× 14 360
Adrian Pereira United Kingdom 9 179 0.2× 158 0.3× 33 0.1× 31 0.4× 3 0.1× 14 402
Martina Antošová Slovakia 12 125 0.2× 146 0.2× 35 0.1× 68 0.9× 2 0.1× 34 352
J W Honour United Kingdom 13 138 0.2× 122 0.2× 16 0.1× 184 2.4× 11 0.3× 31 535
A. M. Vermeulen Netherlands 12 72 0.1× 27 0.0× 210 0.9× 24 0.3× 119 3.3× 24 358

Countries citing papers authored by Daniel K.C. Lee

Since Specialization
Citations

This map shows the geographic impact of Daniel K.C. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel K.C. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel K.C. Lee more than expected).

Fields of papers citing papers by Daniel K.C. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel K.C. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel K.C. Lee. The network helps show where Daniel K.C. Lee may publish in the future.

Co-authorship network of co-authors of Daniel K.C. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel K.C. Lee. A scholar is included among the top collaborators of Daniel K.C. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel K.C. Lee. Daniel K.C. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Daniel K.C., et al.. (2025). ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma. Molecular Oncology. 19(11). 3342–3359.
2.
Lee, Daniel K.C., et al.. (2025). A microRNA CRISPR screen reveals microRNA-483-3p as an apoptotic regulator in prostate cancer cells. Cell Death and Disease. 16(1). 752–752. 1 indexed citations
3.
Campos, Cecília Bonolo de, Zhihua Li, Daniel K.C. Lee, et al.. (2025). PIKfyve inhibition in MM disrupts autophagy and lysosome function, increasing MHC expression and cholesterol metabolism. Blood. 147(6). 650–661. 1 indexed citations
4.
Lee, Daniel K.C.. (2007). Suspected lung cancer: its initial management and staging. Primary Care Respiratory Journal. 16(2). 106–111. 2 indexed citations
5.
Currie, Graeme P., Daniel K.C. Lee, & Brian J. Lipworth. (2006). Long-Acting ??2-Agonists in Asthma. Drug Safety. 29(8). 647–656. 16 indexed citations
6.
Currie, Graeme P. & Daniel K.C. Lee. (2005). Beneficial Antiinflammatory Effects of Leukotriene Receptor Antagonists in Asthma. CHEST Journal. 127(4). 1458–1458.
7.
Currie, Graeme P., et al.. (2005). Long-Acting Bronchodilator or Leukotriene Modifier as Add-on Therapy to Inhaled Corticosteroids in Persistent Asthma?. CHEST Journal. 128(4). 2954–2962. 29 indexed citations
8.
Fardon, Tom, et al.. (2005). Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma. Annals of Allergy Asthma & Immunology. 95(3). 259–265. 10 indexed citations
9.
Lee, Daniel K.C., et al.. (2005). Airway and Systemic Effects of Hydrofluoroalkane Formulations of High-Dose Ciclesonide and Fluticasone in Moderate Persistent Asthma. CHEST Journal. 127(3). 851–860. 57 indexed citations
10.
Currie, Graeme P., Graham Devereux, Daniel K.C. Lee, & Jon G. Ayres. (2005). Recent developments in asthma management. BMJ. 330(7491). 585–589. 18 indexed citations
11.
Fardon, Tom, Daniel K.C. Lee, Kay Haggart, Lesley C. McFarlane, & Brian J. Lipworth. (2004). Adrenal Suppression with Dry Powder Formulations of Fluticasone Propionate and Mometasone Furoate. American Journal of Respiratory and Critical Care Medicine. 170(9). 960–966. 63 indexed citations
12.
Lee, Daniel K.C., Catherine Jackson, Kay Haggart, & Brian J. Lipworth. (2004). Repeated Dosing Effects of Mediator Antagonists in Inhaled Corticosteroid-Treated Atopic Asthmatic Patients. CHEST Journal. 125(4). 1372–1377. 16 indexed citations
13.
Lee, Daniel K.C., Kay Haggart, & Brian J. Lipworth. (2004). Reproducibility of response to nasal lysine-aspirin challenge in patients with aspirin-induced asthma. Annals of Allergy Asthma & Immunology. 93(2). 185–188. 13 indexed citations
14.
Lee, Daniel K.C., et al.. (2004). Single and short‐term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma. British Journal of Clinical Pharmacology. 58(1). 34–39. 18 indexed citations
15.
Lee, Daniel K.C., et al.. (2004). Effects of single or combined histamine H1‐receptor and leukotriene CysLT1‐receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis. British Journal of Clinical Pharmacology. 57(6). 714–719. 20 indexed citations
16.
Currie, Graeme P., et al.. (2003). Effects of Montelukast on Surrogate Inflammatory Markers in Corticosteroid-treated Patients with Asthma. American Journal of Respiratory and Critical Care Medicine. 167(9). 1232–1238. 89 indexed citations
17.
Lee, Daniel K.C., et al.. (2003). Acute systemic effects of inhaled salbutamol in asthmatic subjects expressing common homozygous β2‐adrenoceptor haplotypes at positions 16 and 27. British Journal of Clinical Pharmacology. 57(1). 100–104. 17 indexed citations
18.
Currie, Graeme P., et al.. (2003). Leukotriene C4 synthase polymorphisms and responsiveness to leukotriene antagonists in asthma. British Journal of Clinical Pharmacology. 56(4). 422–426. 31 indexed citations
19.
Lee, Daniel K.C., Graeme P. Currie, Ian P. Hall, John J. Lima, & Brian J. Lipworth. (2003). The arginine‐16 β2‐adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. British Journal of Clinical Pharmacology. 57(1). 68–75. 78 indexed citations
20.
Currie, Graeme P., et al.. (2003). A proof of concept study to evaluate putative benefits of montelukast in moderate persistent asthmatics. British Journal of Clinical Pharmacology. 55(6). 609–615. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Stricker Breakdown of academic impact, for papers by Kay Haggart Breakdown of academic impact, for papers by Dorothy J. Margolskee Breakdown of academic impact, for papers by Robert Murdoch Breakdown of academic impact, for papers by Sümeyye Alparslan Bekir Breakdown of academic impact, for papers by Larry Gontovnick Breakdown of academic impact, for papers by Adrian Pereira Breakdown of academic impact, for papers by Martina Antošová Breakdown of academic impact, for papers by J W Honour Breakdown of academic impact, for papers by A. M. Vermeulen
Rankless by CCL
2026